Injectable
Maxozol 100
100 mg
Maxozol 100 is a sterile injectable stanozolol formulation. Stanozolol is a synthetic anabolic-androgenic compound derived from dihydrotestosterone and does not convert to estrogen.
Product Summary
- Product
- Maxozol 100
- Strength
- 100 mg
- Dosage Form
- Injectable
Product Information
Professional injectable product profile.
Product overview: Maxozol 100 is a sterile injectable stanozolol formulation containing Stanozolol USP 100 mg with sterile water for injection, benzyl benzoate, and benzyl alcohol as stated in the source.
Background and context: Stanozolol is described as a synthetic anabolic-androgenic compound derived from dihydrotestosterone. The source notes that it does not convert to estrogen, but that characteristic must be presented carefully and never as a safety claim.
Important considerations: Injectable administration does not remove hepatic, lipid, cardiovascular, endocrine, or virilisation risks. This page avoids cosmetic or physique promises and presents only formulation identity, composition, and risk context for professional review. The non-estrogen-converting characteristic is not framed as evidence of overall safety. Sterile-water composition is listed exactly as a product specification.
| Product name | Maxozol 100 |
|---|---|
| Strength | 100 mg |
| Active ingredient or blend | Stanozolol |
| Composition | Stanozolol USP 100 mg Sterile water for injection Benzyl benzoate Benzyl alcohol |
| Dosage form | Sterile injectable preparation |
| Carrier oil | Sterile water for injection; benzyl benzoate; benzyl alcohol |
| Pharmaceutical grade | Sterile injectable preparation stated in the source |
Inquiry
Request product information for Maxozol 100.
For product enquiries, portfolio discussion, or category coordination, email info@3xpharma.com.